Aggregation of Therapeutic Proteins / Edition 1

Hardcover (Print)
Used and New from Other Sellers
Used and New from Other Sellers
from $110.21
Usually ships in 1-2 business days
(Save 22%)
Other sellers (Hardcover)
  • All (7) from $110.21   
  • New (6) from $110.21   
  • Used (1) from $110.75   

Overview

This book gives pharmaceutical scientists an up-to-date resource on protein aggregation and its consequences, and available methods to control or slow down the aggregation process. While significant progress has been made in the past decade, the current understanding of protein aggregation and its consequences is still immature. Prevention or even moderate inhibition of protein aggregation has been mostly experimental. The knowledge in this book can greatly help pharmaceutical scientists in the development of therapeutic proteins, and also instigate further scientific investigations in this area. This book fills such a need by providing an overview on the causes, consequences, characterization, and control of the aggregation of therapeutic proteins.

Read More Show Less

Editorial Reviews

From the Publisher
"Among their topics are fundamental structures and behaviors of proteins; protein aggregation pathways, kinetics, and thermodynamics; the identification and impact of aggregate-prone regions in proteins and therapeutic monoclonal antibodies; external factors affecting protein aggregation; experimental detection and characterization of protein aggregates; approaches to controlling it during bulk production; effects of formulation interfaces, and drug product manufacturing operations on aggregation and particle formation; approaches to managing it in product development; aggregation and immunogenicity of therapeutic proteins; and a regulatory perspective on aggregates as a product quality attribute." (SciTech Book News, December 2010)
Read More Show Less

Product Details

  • ISBN-13: 9780470411964
  • Publisher: Wiley
  • Publication date: 8/30/2010
  • Edition number: 1
  • Pages: 484
  • Product dimensions: 6.30 (w) x 9.30 (h) x 1.10 (d)

Meet the Author

WEI WANG, PhD, is a Research Fellow at Pfizer Global Biologics. He is also Adjunct Professor in the School of Pharmacy and Health at the University of the Pacific in California and Guest Professor at Shandong University in China.

CHRISTOPHER J. ROBERTS, PhD, is Associate Professor of Chemical Engineering at the University of Delaware. Previously, he was a senior research scientist in pharmaceutical R & D at Pfizer.

Read More Show Less

Table of Contents

Preface.

Contributors.

1. Fundamental Structures and Behaviors of Proteins (Jennifer S. Laurence and C. Russell Middaugh).

1.1 The Problem of Protein Aggregation.

1.2 Parallels to Protein Folding.

1.3 Views of Protein Stability and Aggregation.

1.4 Models of Aggregation.

1.5 Models of Protein Folding.

1.6 Infl uences of Chemical Alteration on Aggregation.

1.7 Approaches to Predicting Aggregation.

1.8 Conclusions.

2. Protein Aggregation Pathways, Kinetics, and Thermodynamics (Yi Li and Christopher J. Roberts).

2.1 Introduction.

2.2 Native and Nonnative Aggregation Pathways.

2.3 Thermodynamics of Reversible Self-Association.

2.4 Aggregation Kinetics and Distinguishing Kinetic Pathways.

2.5 Chemical Modifi cations.

2.6 Effects of Cosolvents or Cosolutes.

3. Identifi cation and Impact of Aggregation-Prone Regions in Proteins and Therapeutic Monoclonal Antibodies (Sandeep Kumar, Xiaoling Wang, and Satish K. Singh).

3.1 Introduction.

3.2 Energy Landscapes, Protein Folding, and Aggregation.

3.3 Prediction of APRs in Proteins and Biotherapeutics.

3.4 Conclusions and Future Directions.

4. External Factors Affecting Protein Aggregation (Wei Wang, Ning Li, and Stan Speaker).

4.1 Introduction.

4.2 Protein Aggregation Pathways.

4.3 Effects of Temperature.

4.4 Effects of Solution Conditions and Composition on Protein Aggregation.

4.5 Effects of Processing Steps on Protein Aggregation.

4.6 Effects of Solid-State Condition and Composition on Protein Aggregation.

4.7 Summary.

5. Experimental Detection and Characterization of Protein Aggregates (Vikas K. Sharma and Devendra S. Kalonia).

5.1 Introduction.

5.2 Aggregate Classifi cation.

5.3 Analytical Tools for the Characterization of Aggregates.

5.4 Summary.

6. Approaches to Control Protein Aggregation during Bulk Production (Linda O. Narhi, Yijia Jiang, Rohini Deshpande, Sohye Kang, and Joseph Shultz).

6.1 Introduction.

6.2 Candidate Selection.

6.3 Protein Aggregation and Cell Culture.

6.4 Protein Aggregation and Purifi cation.

6.5 Summary.

7. Protein Aggregation and Particle Formation: Effects of Formulation, Interfaces, and Drug Product Manufacturing Operations (Hanns-Christian Mahler, Stefan Fischer, Theodore W. Randolph, and John F. Carpenter).

7.1 Introduction.

7.2 Roles of Conformational and Colloidal Stability in Reducing Rates of Aggregation.

7.3 Effects of Interfaces on Protein Aggregation.

7.4 Critical Processing Steps during Drug Product Manufacturing of Biopharmaceuticals.

7.5 Particles in Parenteral Products and Visible Inspection.

7.6 Summary and Outlook.

8. Approaches to Managing Protein Aggregation in Product Development (Wei Wang and Nicholas W. Warne).

8.1 Introduction.

8.2 Approaches in Formulation Development.

8.3 Protection of Proteins in Various Processing Steps.

8.4 Aggregation Control by Structural Modifi cations.

8.5 Summary.

9. Case Studies Involving Protein Aggregation (Rahul S. Rajan, Tiansheng Li, and Tsutomu Arakawa).

9.1 Introduction.

9.2 Case Study 1: Aggregation in the Liquid State: The Role of Osmolytes in Stabilizing KGF toward Aggregation.

9.3 Case Study 2: Aggregation in the Liquid State: Heterogeneity and Non-Linearity in IgG2 Aggregation during Long-Term Storage.

9.4 Case Study 3: Aggregation in the Frozen State: The Role of Excipient Crystallization.

9.5 Case Studies 4 and 5: Aggregation in the Lyophilized State: Role of Residual Moisture and Mechanisms of Excipient Stabilization.

9.6 Case Study 6: Protein Particulation Due to Nucleation by Foreign Material in Fill/Finish Manufacturing Operations.

9.7 Overall Discussion.

10. Aggregation and Immunogenicity of Therapeutic Proteins (Vasco Filipe, Andrea Hawe, Huub Schellekens, and Wim Jiskoot).

10.1 Introduction.

10.2 Immunogenicity of Therapeutic Proteins.

10.3 Immune Mechanisms Related to Protein Immunogenicity.

10.4 Aggregates and Immunogenicity.

10.5 Conclusions.

11. Regulatory Perspective on Aggregates as a Product Quality Attribute (Wendy C. Weinberg, Linan Ha, Susan L. Kirshner, and Daniela I. Verthelyi).

11.1 Introduction.

11.2 An Overview of the Regulatory Process.

11.3 Product Aggregates and Safety Concerns.

11.4 The Assessment of Aggregates: Regulatory Approaches to Controlling Product Aggregation.

11.5 Future Challenges.

11.6 Summary.

Index.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)